Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Agnosia × Diathermy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 5 Neoplasm Metastasis 4 Colonic Neoplasms 4 Prostatic Neoplasms 3 Rectal Neoplasms 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Hyperthermia 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pelvic Pain 1 Ovarian Neoplasms 1 Obesity 1 Neurofibrosarcoma 1 Neoplasms, Radiation-Induced 1 Metabolic Syndrome 1 Liver Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1

Interventions

Anesthesia, General 6 Analgesics, Opioid 6 Ropivacaine 4 Morphine 4 Fentanyl 4 Sodium Chloride 3 Lidocaine 3 Ketamine 3 Dexmedetomidine 3 Anesthetics, Local 3 Acupuncture Therapy 3 Acetaminophen 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Tramadol 2 Tea 2 Surveys and Questionnaires 2 Saline Solution 2 Propofol 2 Magnesium Sulfate 2 Levobupivacaine 2 Control Groups 2 Bupivacaine 2 Anesthesia, Local 2 ramosetron 1 parecoxib 1 acetaminophen, codeine drug combination 1 Varenicline 1 Uterine Myomectomy 1 Transcranial Direct Current Stimulation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡